Literature DB >> 6613469

Altered intestinal permeability to low-molecular-weight polyethyleneglycols (PEG 400) in patients with Crohn's disease.

K E Magnusson, T Sundqvist, R Sjödahl, C Tagesson.   

Abstract

The passive intestinal permeability to different-sized low-molecular weight polyethyleneglycols (PEG 400) was studied in 24 patients with Crohn's disease, which were compared to 24 healthy persons. The recovery in 6-hour urine after oral intake was significantly lower (p less than 0.0005-0.005) in the subjects with Crohn's disease for molecules ranging between 282 and 546 in molecular weight. Mathematical modelling of the filtering properties demonstrated a lower filtering efficiency of the larger polyethyleneglycols in the patients than in the healthy individuals. The coefficient of variation for the different polymers was larger in the group of Crohn's disease patients, indicating greater heterogeneity in the intestinal filtering efficiency. In two patients the intestinal uptake of the probe molecules was increased 6 weeks after resectional surgery compared to the uptake before operation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6613469

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  10 in total

1.  PEG-400 excretion in patients with Crohn's disease, their first-degree relatives, and healthy volunteers.

Authors:  D Ruttenberg; G O Young; J P Wright; S Isaacs
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

2.  Assessment of the lactulose-mannitol test in Crohn's disease.

Authors:  F Andre; C Andre; Y Emery; J Forichon; L Descos; Y Minaire
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

Review 3.  Helping the mucosa make sense of macromolecules.

Authors:  I Bjarnason; J Peters
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

4.  Intestinal permeability to polyethyleneglycol 600 in Crohn's disease. Peroperative determination in a defined segment of the small intestine.

Authors:  G Olaison; P Leandersson; R Sjödahl; C Tagesson
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

5.  Mathematical modelling for determining intestinal permeability using polyethyleneglycol.

Authors:  K E Magnusson; T Sundqvist
Journal:  Gut       Date:  1984-04       Impact factor: 23.059

6.  Intestinal permeability in patients with Crohn's disease and their first degree relatives.

Authors:  K Teahon; P Smethurst; A J Levi; I S Menzies; I Bjarnason
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

7.  Improvement of abnormal lactulose/rhamnose permeability in active Crohn's disease of the small bowel by an elemental diet.

Authors:  I R Sanderson; P Boulton; I Menzies; J A Walker-Smith
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

8.  Effect of N-formylated methionyl-phenylalanine (FMP) and methionyl-leucyl-phenylalanine (FMLP) on gut permeability. A model of local inflammatory process.

Authors:  K E Magnusson; C Dahlgren; A Sjölander
Journal:  Inflammation       Date:  1985-12       Impact factor: 4.092

9.  Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure.

Authors:  M Magnusson; K E Magnusson; T Sundqvist; T Denneberg
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

10.  Intestinal permeability in patients with yersinia triggered reactive arthritis.

Authors:  R Lahesmaa-Rantala; K E Magnusson; K Granfors; R Leino; T Sundqvist; A Toivanen
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.